Jackson Mthembu’s death drives home the seriousness of the COVID-19 pandemic in the country.
Academic rigour, journalistic flair
Articles on Public health
Displaying 821 - 840 of 2127 articles
Scientists have observed that 501Y.V2 has quickly become “dominant” among multiple variants that have been circulating in the South African population.
The pervasive impacts of infrastructure projects on public health are often overlooked. New research is teasing out the many ways Melbourne’s level-crossing removals will affect people’s health.
Vaccine hesitancy has resulted in multiple vaccine-preventable disease outbreaks. Research on vaccine hesitancy in South Africa is limited. But growing evidence suggests that it’s becoming a problem.
When a pandemic hits, questions that immediately arise include what impact there will be on public health, the economy and other aspects of society. Another set of questions involves response priorities…
From designing vaccine supply chains to improving PPE to rebuilding trust, systematically bringing engineering knowhow to public health problems could make a huge difference.
CC BY-NC-ND13.3 MB (download)
Nigeria needs a coherent plan to get COVID-19 vaccines.
If South Africa is serious about being able to supply anti-pandemic vaccines in future, it needs to rethink the scale of financial, technical and strategic investment into vaccine production.
African leaders can make strategies to fight COVID-19 more accessible to the people.
COVID-19 restrictions created life-threatening challenges to female sex workers as they weren’t able to access their medication, support or their clients.
The African Vaccine Acquisition Task Team recently secured a provisional 270 million vaccine doses for African countries.
The health and wellbeing effects will go beyond the direct impact of war-related fatalities, and are likely to last for years after peace is fully restored.
In the early years of the United States, several American presidents were in favour of public health inoculation and vaccination strategies.
Critics of the South African government argue that it has done too little too late to secure vaccines, and that it doesn’t have a proper plan in place for rollout.
Many countries cannot afford to buy existing COVID-19 vaccines, a collective approach is needed.
CC BY-NC-ND16.4 MB (download)
It’s unlikely South Africa will have a substantial number of vaccines until the second half of this year. Most of the vaccines produced in Europe or America have been bought by other countries.
Local and national governments in west and central African countries must prioritise investment in providing access to HIV testing for all pregnant women.
States and hospitals are starting to declare ‘crisis standards of care’ as the pandemic floods their ERs. The orders have consequences – both good and bad, as a medical ethicist explains.
The built environment plays a pivotal role in lowering residents’ exposure to climate change driven risks.
So far, the only COVID-19 vaccines authorized for use need to be kept frozen. But there are many places in the world that can’t support a cold supply chain.
Top contributors
-
Emeritus Professor in Public Health, University of Sydney
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Principal Medical Scientist and Head of Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, National Institute for Communicable Diseases
-
Research Scientist, African Population and Health Research Center
-
Executive Secretary, Nigerian Academy of Science
-
Medical scientist, National Institute for Communicable Diseases
-
Professor and Programme Director, SA MRC Centre for Health Economics and Decision Science - PRICELESS SA (Priority Cost Effective Lessons in Systems Strengthening South Africa), University of the Witwatersrand
-
Regional Adviser, Immunisation, WHO Regional Office for Africa, Stellenbosch University
-
Distinguished Professor in the Department of Medicine and Director, The Centre for Medical Ethics & Law, Stellenbosch University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Professor in the faculty of Medicine, Mbarara University of Science and Technology
-
Fellow, Nigerian Academy of Science
-
Vice Chancellor, University of Global Health Equity
-
Associate Professor, Epidemiology, Deakin University
-
Medical Entomologist at the School of Biological Sciences, University of Nairobi
